Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS

Neuroscience
C CortiF Ferraguti

Abstract

Group III metabotropic glutamate receptors (mGluRs) are selectively activated by L-2-amino-4-phosphonobutyrate (L-AP4), which produces depression of synaptic transmission. The relative contribution of different group III mGluRs to the effects of L-AP4 remains to be clarified. Here, we assessed the distribution of mGluR4 in the rat and mouse brain using affinity-purified antibodies raised against its entire C-terminal domain. The antibodies reacted specifically with mGluR4 and not with other mGluRs in transfected COS 7 cells. No immunoreactivity was detected in brains of mice with gene-targeted deletion of mGluR4. Pre-embedding immunocytochemistry for light and electron microscopy showed the most intense labelling in the cerebellar cortex, basal ganglia, the sensory relay nuclei of the thalamus, and some hippocampal areas. Immunolabelling was most intense in presynaptic active zones. In the basal ganglia, both the direct and indirect striatal output pathways showed immunolabelled terminals forming mostly type II synapses on dendritic shafts. The localisation of mGluR4 on GABAergic terminals of striatal projection neurones suggests a role as a presynaptic heteroreceptor. In the cerebellar cortex and hippocampus, mGluR4 was also l...Continue Reading

References

Jul 1, 1990·Trends in Neurosciences·A M Graybiel
Jan 1, 1995·Neuropharmacology·J P Pin, R Duvoisin
May 8, 1995·The Journal of Comparative Neurology·C RomanoJ W Olney
Jan 1, 1995·Brain Research. Brain Research Reviews·A Parent, L N Hazrati
Sep 15, 1994·European Journal of Pharmacology·P CavanniF Ferraguti
Oct 1, 1993·The European Journal of Neuroscience·P CalabresiG Bernardi
Dec 1, 1995·British Journal of Pharmacology·L Eriksen, C Thomsen
Apr 1, 1996·Brain Research. Molecular Brain Research·A MakoffP Emson
Dec 1, 1996·Cell and Tissue Research·T DellerM Frotscher
Jan 1, 1997·Neuropharmacology·C ThomsenD R Hampson
Aug 1, 1997·General Pharmacology·C Thomsen
Mar 21, 1998·Histochemistry and Cell Biology·J M MateosT Knöpfel
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M ScanzianiS Charpak
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·K E Vogt, R A Nicoll
Oct 26, 1999·Neuropharmacology·D D SchoeppJ A Monn
Oct 29, 2000·Trends in Neurosciences·A ParentM Parent

❮ Previous
Next ❯

Citations

Jul 19, 2006·Cell and Tissue Research·Francesco Ferraguti, Ryuichi Shigemoto
Oct 1, 2013·Frontiers of Medicine·Limin MaoJohn Q Wang
Dec 14, 2011·Journal of Molecular Neuroscience : MN·J S SchneiderD W Anderson
May 12, 2011·Molecular Neurobiology·Kathleen E CosgroveStephen D Meriney
Jun 5, 2003·Pharmacology & Therapeutics·Jean-Philippe PinLaurent Prézeau
Sep 12, 2003·Trends in Pharmacological Sciences·Domenico E Pellegrini-Giampietro
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Jul 27, 2010·Nature Medicine·Francesca FallarinoRoberto Di Marco
Nov 9, 2005·Nature Reviews. Neuroscience·P Jeffrey ConnFerdinando Nicoletti
Oct 25, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Karl EbnerNicolas Singewald
Aug 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Martin BalastikPeter Gruss
Apr 25, 2012·The Journal of Biological Chemistry·Cathy RamosPierre Le Maréchal
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Colleen M Niswender, P Jeffrey Conn
Mar 26, 2013·Neurodegenerative Disease Management·Jonathan W Dickerson, P Jeffrey Conn
Feb 18, 2010·Future Medicinal Chemistry·Corey R HopkinsColleen M Niswender
Nov 1, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michael J MarinoP Jeffrey Conn
Dec 24, 2013·Pharmacology & Therapeutics·Lucyna Pomierny-ChamiołoMałgorzata Filip
Aug 26, 2014·Neurochemical Research·Marion S Mercier, David Lodge
Mar 13, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jérôme A J BeckerBrigitte L Kieffer
Jul 31, 2014·Journal of the Neurological Sciences·Aakanksha DubeChandrashekhar Devidas Upasani
Jan 10, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Christine L Kyuyoung, John R Huguenard
Dec 19, 2014·Expert Opinion on Investigational Drugs·Jacob Raber, Robert M Duvoisin
Feb 7, 2012·Progress in Neurobiology·Katherine M BetkeHeidi E Hamm
Jan 10, 2012·Behavioural Brain Research·Matthew J DavisJacob Raber
Sep 15, 2009·Brain Research·Jordan E AntflickDavid R Hampson
Dec 16, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Slavianka G MoyanovaRichard T Ngomba
Jul 17, 2012·Neuron·Thomas C Südhof

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.